This article has been corrected: The following author has been added to the author list:
Massimo Morra
1Personalis, Inc., Fremont, CA 94555, USA
Original article: Oncotarget. 2024; 15:200–218. 200-218. https://doi.org/10.18632/oncotarget.28565
. 2024 Jun 20;15:407. doi: 10.18632/oncotarget.28581
Correction: Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay
Josette Northcott
1, Gabor Bartha
1, Jason Harris
1, Conan Li
1, Fabio CP Navarro
1, Rachel Marty Pyke
1, Manqing Hong
1, Qi Zhang
1, Shuyuan Ma
1, Tina X Chen
1, Janet Lai
1, Nitin Udar
1, Juan-Sebastian Saldivar
1, Erin Ayash
1, Joshua Anderson
1, Jiang Li
1, Tiange Cui
1, Tu Le
1, Ruthie Chow
1, Randy Jerel Velasco
1, Chris Mallo
1, Rose Santiago
1, Robert C Bruce
1, Laurie J Goodman
1, Yi Chen
1, Dan Norton
1, Richard O Chen
1,*, John M Lyle
1,*,✉
Juan-Sebastian Saldivar
1Personalis, Inc., Fremont, CA 94555, USA
Find articles by Juan-Sebastian Saldivar
Richard O Chen
1Personalis, Inc., Fremont, CA 94555, USA
*Co-last authors
Find articles by Richard O Chen
1Personalis, Inc., Fremont, CA 94555, USA
*Co-last authors
✉
Correspondence to: John M. Lyle, email : john.lyle@personalis.com
Collection date 2024.
Copyright: © 2024 Northcott et al.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PMCID: PMC11197971 PMID: 38900651
This corrects the article "Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay" on page 200.